BackgroundRecently, the ever growing number of immunocompromized patients, generally using of antibiotics, organ transplantand, urethral catheterization, chemo-theropy for cancer and increasing travel to areas where fungal diseases are endemic explain why in recent years mycoses have emerged as important infections in clinical practice. Cellular immunodeficiency could account for the chronic nature of the disease and for its refractoriness to drug treatment. It is essential that pathologists and clinicians be knowledgeable about them. Fungal infections of the urinary tract, respiratory tract and invasive fungal infections are increasing in incidence, themostly because of the increasing use of antibacterial agents, indwelling urinary catheters, mechanical ventilation and chemotherapy treatment.According to the data from abroad,the predominant causative agents were Candida and Aspergillus, at approximately the same rate (Candida 33.6%, Aspergillus 33.3%) as in 1989.
|